Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon [5]

Acta Dermato-Venereologica

Volumn 86, Issue 2, 2006, Pages 161-162

  Fujimura, Taku ^a   Okuyama, Ryuhei ^a   Hashimoto, Akira ^a   Watanabe, Hiroshi ^a   Nakagawa, Satoshi ^a   Tagami, Hachiro ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; BLOOD CELL COUNT; CANCER CONTROL; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; ELECTRON THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LYMPHOCYTIC INFILTRATION; MYCOSIS FUNGOIDES; PARAPSORIASIS; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON ALFA-2A; MYCOSIS FUNGOIDES; NEOPLASM RECURRENCE, LOCAL; POLYETHYLENE GLYCOLS; RADIOTHERAPY, HIGH-ENERGY; SKIN NEOPLASMS;

EID: 33745779896     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0017     Document Type: Letter

References (7)

1. Bekkenk MW, Vermeer MH, Jansen PM, van Marion AM, Canninga-van Dijk MR, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factor in a group of 82 patients. Blood 2003; 102: 2213-2219.
2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
3. Lu D, Patel KA, Duvic M, Jones D. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 2002; 29: 465-472.
4. Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's lymphoma classification project. Ann Oncol 2002; 13: 140-149.
5. Fujimura T, Aiba S, Yoshino Y, Kuroki S, Kimura Y, Kikuchi K, et al. CCR4 expression by atypical T cells in systemic pilotrophic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid. Dermatology 2004; 208: 221-226.
6. Suchin KR, Cucchiara AJ, Gottleib SL, Gottleib SL, Wolfe JT, DeNardo BJ, et al. Treatment of cutaneous T cell lymphoma with combined immunomodulatory therapy. Arch Dermatol 2002; 138: 1054-1060.
7. Pichardo DA, Querfeld C, Guitart J, Kuzel TM, Rosen ST. Cutaneous T cell lymphoma: a paradigm for biological treatment. Leuk Lymphoma 2004; 45: 1755-1765.